Correction: Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors

Correction: Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-11-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/12/11/e009893corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors
by: Ying Li, et al.
Published: (2024-10-01)

Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors
by: Dong Hyun Kim, et al.
Published: (2024-11-01)

Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma
by: Xuri Zhao, et al.
Published: (2025-05-01)

Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
by: Marianna Caterino, et al.
Published: (2025-05-01)

VPS25 Promotes an Immunosuppressive Microenvironment in Head and Neck Squamous Cell Carcinoma
by: Li-Guo Chen, et al.
Published: (2025-02-01)

Characteristics of inflammatory reactions in the tumor microenvironment of head and neck squamous cell carcinoma
by: V. A. Bychkov, et al.
Published: (2019-01-01)

Integrating metabolism gene clusters and tumor immune microenvironment in head and neck squamous cell carcinoma
by: Meina Lian, et al.
Published: (2025-06-01)

Expert consensus on the combination of anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma (2025 edition)
by: XUE Liqiong, XU Tingting, GUO Ye, HU Chaosu
Published: (2025-05-01)

The correlation between MTHFD2 and the tumor microenvironment in head and neck squamous cell carcinoma
by: SHI Zhenxiang, et al.
Published: (2024-03-01)

Mapping immunotherapy potential: spatial transcriptomics in the unraveling of tumor-immune microenvironments in head and neck squamous cell carcinoma
by: Seo-Won Choi, et al.
Published: (2025-04-01)

Prognostic and therapeutic insights from lactate metabolism and tumor immune microenvironment in head and neck squamous cell carcinoma
by: Huanyu Jiang, et al.
Published: (2025-05-01)

Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma
by: Daniel A. Ruiz-Torres, et al.
Published: (2025-12-01)

Survival Outcomes in T3N0 versus N1 in Head and Neck Cutaneous Squamous Cell Carcinoma – Implications for Neoadjuvant Immune Checkpoint Inhibitor Immunotherapy
by: A.E. Yung, et al.
Published: (2024-01-01)

Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells
by: Anna R. Bopp, et al.
Published: (2025-05-01)

CBD promotes antitumor activity by modulating tumor immune microenvironment in HPV associated head and neck squamous cell carcinoma
by: Prakriti Sen, et al.
Published: (2025-05-01)

Emerging immune checkpoint inhibitors for the treatment of oropharyngeal squamous cell carcinoma
by: Pandiselvi Ravi, et al.
Published: (2024-12-01)

Causal role of immune cells in head and neck squamous cell carcinoma
by: Panshu Xu, et al.
Published: (2025-03-01)

A Cell Component-Related Prognostic Signature for Head and Neck Squamous Cell Carcinoma Based on the Tumor Microenvironment
by: Siyu Li, et al.
Published: (2022-01-01)

The Impact of Hydrogen Sulfide Regulatory Gene Alterations on Head and neck squamous cell carcinoma prognosis and tumor microenvironment
by: Mohamed Rizwan Ghouse, et al.
Published: (2025-04-01)

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
by: Matthias Preusser, et al.
Published: (2022-03-01)

Editorial: Opportunities and challenges of head and neck cancer treatment in the era of immune checkpoint inhibitors
by: Zheran Liu, et al.
Published: (2025-07-01)

p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
by: Wen-Liang Kuo, et al.
Published: (2014-01-01)

Molecular features of head and neck squamous cell carcinoma
by: G. V. Kakurina, et al.
Published: (2018-09-01)

Clinicopathological profile of head and neck squamous cell carcinoma
by: Senjuti Dasgupta, et al.
Published: (2019-01-01)

Correction: AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK.
by: Derek J Essegian, et al.
Published: (2023-11-01)

Multiplexed immune profiling and 3D co-culture assays to assess the individual checkpoint therapy response in head and neck squamous cell carcinoma
by: Verena Schweihofer, et al.
Published: (2025-08-01)

A prognostic model for head and neck squamous cell carcinoma based on radiotherapy sensitivity insights from nasopharyngeal carcinoma
by: Yinjiao Fei, et al.
Published: (2025-05-01)

Marine peptides as new therapeutic tools for inhibiting signaling pathways of head and neck squamous cell carcinoma
by: E. Dilipan, et al.
Published: (2023-09-01)

Prospects of epigenetic therapy of head and neck squamous cell carcinoma
by: R. N. Mustafin
Published: (2023-09-01)

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
by: Muzaffar Shah-Khan, et al.
Published: (2013-03-01)

Risk Factors and Diagnosis of Head and Neck Squamous Cell Carcinoma
by: Yussy Afriani Dewi, et al.
Published: (2024-12-01)

EXPRESSION PROFILE OF MICRORNAS IN SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: Yu. A. Veryaskina, et al.
Published: (2016-02-01)

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?
by: T. Braunschweig, et al.
Published: (2015-04-01)

Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model
by: Felipe F. Lamenza, et al.
Published: (2025-12-01)

Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis.
by: Priyan Bhattacharya, et al.
Published: (2025-06-01)

Circadian Regulator-Mediated Molecular Subtypes Depict the Features of Tumor Microenvironment and Indicate Prognosis in Head and Neck Squamous Cell Carcinoma
by: Ling Aye, et al.
Published: (2023-01-01)

Ezrin drives adaptation of monocytes to the inflamed lung microenvironment
by: Ravindra Gudneppanavar, et al.
Published: (2024-11-01)

Contrast-enhanced ultrasound in the diagnosis of head and neck squamous cell carcinoma
by: G. F. Allakhverdieva, et al.
Published: (2019-04-01)

Methylation of the tumor associated genes in head and neck squamous cell carcinoma
by: S. V. Kurevlev, et al.
Published: (2023-03-01)

Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
by: Aidan G. Major, et al.
Published: (2013-01-01)